{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:41:18Z","timestamp":1791996078009,"version":"4.4.0"},"reference-count":96,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T00:00:00Z","timestamp":1647820800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Vancomycin is a hydrophilic antibiotic widely used in severe infections, including bacteremia and central nervous system (CNS) infections caused by Gram-positive bacteria such as methicillin-resistant <jats:italic>Staphylococcus aureus<\/jats:italic> (MRSA), coagulase-negative staphylococci and enterococci. Appropriate antimicrobial dosage regimens can help achieve the target exposure and improve clinical outcomes. However, vancomycin exposure in serum and cerebrospinal fluid (CSF) is challenging to predict due to rapidly changing pathophysiological processes and patient-specific factors. Vancomycin concentrations may be decreased for peripheral infections due to augmented renal clearance (ARC) and increased distribution caused by systemic inflammatory response syndrome (SIRS), increased capillary permeability, and aggressive fluid resuscitation. Additionally, few studies on vancomycin\u2019s pharmacokinetics (PK) in CSF for CNS infections. The relationship between exposure and clinical response is unclear, challenging for adequate antimicrobial therapy. Accurate prediction of vancomycin pharmacokinetics\/pharmacodynamics (PK\/PD) in patients with high interindividual variation is critical to increase the likelihood of achieving therapeutic targets. In this review, we describe the interaction between ARC and vancomycin PK\/PD, patient-specific factors that influence the achievement of target exposure, and recent advances in optimizing vancomycin dosing schedules for severe infective patients with ARC.<\/jats:p>","DOI":"10.3389\/fphar.2022.835557","type":"journal-article","created":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T19:20:51Z","timestamp":1647890451000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":20,"title":["Augmented Renal Clearance in Severe Infections\u2014An Important Consideration in Vancomycin Dosing: A Narrative Review"],"prefix":"10.3389","volume":"13","author":[{"given":"Qile","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hainan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixia","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,3,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1002\/jcph.1254","article-title":"Evaluation of the Effectiveness of Dose Individualization to Achieve Therapeutic Vancomycin Concentrations","volume":"58","author":"Abulfathi","year":"2018","journal-title":"J. Clin. Pharmacol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"224","DOI":"10.3390\/pharmaceutics11050224","article-title":"Application of Pharmacometrics in Pharmacotherapy: Open-Source Software for Vancomycin Therapeutic Drug Management","volume":"11","author":"Bae","year":"2019","journal-title":"Pharmaceutics"},{"key":"B3","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1111\/aas.12897","article-title":"Vancomycin Levels Are Frequently Subtherapeutic in Critically Ill Patients: a Prospective Observational Study","volume":"61","author":"Bakke","year":"2017","journal-title":"Acta Anaesthesiol Scand."},{"key":"B4","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1186\/s13054-014-0654-2","article-title":"Decreasing the Time to Achieve Therapeutic Vancomycin Concentrations in Critically Ill Patients: Developing and Testing of a Dosing Nomogram","volume":"18","author":"Baptista","year":"2014","journal-title":"Crit. Care"},{"key":"B5","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.ijantimicag.2011.12.011","article-title":"Augmented Renal Clearance in Septic Patients and Implications for Vancomycin Optimisation","volume":"39","author":"Baptista","year":"2012","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1097\/TA.0000000000001211","article-title":"The Importance of Empiric Antibiotic Dosing in Critically Ill Trauma Patients: Are We Under-dosing Based on Augmented Renal Clearance and Inaccurate Renal Clearance Estimates?","volume":"81","author":"Barletta","year":"2016","journal-title":"J. Trauma Acute Care Surg."},{"key":"B7","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1097\/TA.0000000000001387","article-title":"Identifying Augmented Renal Clearance in Trauma Patients: Validation of the Augmented Renal Clearance in Trauma Intensive Care Scoring System","volume":"82","author":"Barletta","year":"2017","journal-title":"J. Trauma Acute Care Surg."},{"key":"B8","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1023\/b:jopa.0000029490.76908.0c","article-title":"A Bayesian Approach to Tracking Patients Having Changing Pharmacokinetic Parameters","volume":"31","author":"Bayard","year":"2004","journal-title":"J. Pharmacokinet. Pharmacodyn"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1007\/s40262-017-0548-y","article-title":"Penetration of Vancomycin into the Cerebrospinal Fluid: A Systematic Review","volume":"56","author":"Beach","year":"2017","journal-title":"Clin. Pharmacokinet."},{"key":"B10","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1111\/j.1365-2125.1995.tb05719.x","article-title":"A Suggested Approach to Once-Daily Aminoglycoside Dosing","volume":"39","author":"Begg","year":"1995","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"559671","DOI":"10.3389\/fmed.2020.559671","article-title":"Endotoxemia-Induced Release of Pro-inflammatory Mediators Are Associated with Increased Glomerular Filtration Rate in Humans In Vivo","volume":"7","author":"Beunders","year":"2020","journal-title":"Front. Med. (Lausanne)"},{"key":"B12","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jcrc.2021.02.009","article-title":"Late Augmented Renal Clearance in Patients with COVID-19 in the Intensive Care Unit. A Prospective Observational Study","volume":"6464","author":"Beunders","year":"2021","journal-title":"J. Crit. Care"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1007\/s40262-018-0636-7","article-title":"Augmented Renal Clearance in Critically Ill Patients: A Systematic Review","volume":"57","author":"Bilbao-Meseguer","year":"2018","journal-title":"Clin. Pharmacokinet."},{"key":"B14","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1093\/jac\/dky543","article-title":"CSF Penetration of Vancomycin in Critical Care Patients with Proven or Suspected Ventriculitis: a Prospective Observational Study","volume":"74","author":"Blassmann","year":"2019","journal-title":"J. Antimicrob. Chemother."},{"key":"B15","first-page":"694","article-title":"The Use of Vancomycin with its Therapeutic and Adverse Effects: a Review","volume":"19","author":"Bruniera","year":"2015","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"B16","doi-asserted-by":"publisher","first-page":"13","DOI":"10.5935\/0103-507x.20140003","article-title":"Augmented Renal Clearance in Critically Ill Patients: Incidence, Associated Factors and Effects on Vancomycin Treatment","volume":"26","author":"Campassi","year":"2014","journal-title":"Rev. Bras Ter Intensiva"},{"key":"B17","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1186\/s13054-019-2621-4","article-title":"Increased \u03b2-Lactams Dosing Regimens Improve Clinical Outcome in Critically Ill Patients with Augmented Renal Clearance Treated for a First Episode of Hospital or Ventilator-Acquired Pneumonia: a before and after Study","volume":"23","author":"Carri\u00e9","year":"2019","journal-title":"Crit. Care"},{"key":"B18","doi-asserted-by":"publisher","first-page":"300060520949076","DOI":"10.1177\/0300060520949076","article-title":"Effect of Augmented Renal Clearance on the Therapeutic Drug Monitoring of Vancomycin in Patients after Neurosurgery","volume":"48","author":"Chen","year":"2020","journal-title":"J. Int. Med. Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.jiph.2019.06.016","article-title":"Population Pharmacokinetics of Vancomycin in Chinese Patients with Augmented Renal Clearance","volume":"13","author":"Chu","year":"2020","journal-title":"J. Infect. Public Health"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2598","DOI":"10.1016\/j.clinthera.2016.10.009","article-title":"Duration of Systemic Inflammatory Response Syndrome Influences Serum Vancomycin Concentration in Patients with Sepsis","volume":"38","author":"Chuma","year":"2016","journal-title":"Clin. Ther."},{"key":"B21","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1097\/FTD.0000000000000622","article-title":"Examining the Relationship between Vancomycin Area under the Concentration Time Curve and Serum Trough Levels in Adults with Presumed or Documented Staphylococcal Infections","volume":"41","author":"Clark","year":"2019","journal-title":"Ther. Drug Monit."},{"key":"B22","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s40262-018-0727-5","article-title":"Vancomycin Pharmacokinetics throughout Life: Results from a Pooled Population Analysis and Evaluation of Current Dosing Recommendations","volume":"58","author":"Colin","year":"2019","journal-title":"Clin. Pharmacokinet."},{"key":"B23","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1089\/sur.2019.031","article-title":"Incidence and Risk Factors Associated with Multi-Drug-Resistant Pathogens in a Critically Ill Trauma Population: A Retrospective Cohort Study","volume":"21","author":"Cucci","year":"2020","journal-title":"Surg. Infect. (Larchmt)"},{"key":"B24","doi-asserted-by":"publisher","first-page":"30388","DOI":"10.1016\/j.cmi.2020.07.005","article-title":"Towards Precision Dosing of Vancomycin in Critically Ill Patients: an Evaluation of the Predictive Performance of Pharmacometric Models in ICU Patients","author":"Cunio","year":"2020","journal-title":"Clin. Microbiol. Infect."},{"key":"B25","first-page":"1079","article-title":"Epidemiology of Augmented Renal Clearance in Mixed ICU Patients","volume":"81","author":"De Waele","year":"2015","journal-title":"Minerva Anestesiol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"607101","DOI":"10.3389\/fphar.2020.607101","article-title":"Unraveling the Contribution of Fluid Therapy to the Development of Augmented Renal Clearance in a Piglet Model","volume":"11","author":"Dhondt","year":"2020","journal-title":"Front. Pharmacol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1007\/s12028-014-0045-1","article-title":"Kidney-brain Link in Traumatic Brain Injury Patients? A Preliminary Report","volume":"22","author":"Dias","year":"2015","journal-title":"Neurocrit. Care"},{"key":"B28","doi-asserted-by":"publisher","first-page":"680858","DOI":"10.3389\/fncel.2021.680858","article-title":"Neuronal Damage and Neuroinflammation, a Bridge between Bacterial Meningitis and Neurodegenerative Diseases","volume":"15","author":"Farmen","year":"2021","journal-title":"Front Cel Neurosci"},{"key":"B29","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s40262-012-0020-y","article-title":"Benchmarking Therapeutic Drug Monitoring Software: a Review of Available Computer Tools","volume":"52","author":"Fuchs","year":"2013","journal-title":"Clin. Pharmacokinet."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1111\/bcp.14498","article-title":"Why We Should Sample Sparsely and Aim for a Higher Target: Lessons from Model-Based Therapeutic Drug Monitoring of Vancomycin in Intensive Care Patients","volume":"87","author":"Guo","year":"2021","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"e02543","DOI":"10.1128\/AAC.02543-18","article-title":"External Evaluation of Population Pharmacokinetic Models of Vancomycin in Large Cohorts of Intensive Care Unit Patients","volume":"63","author":"Guo","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"B32","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.21037\/tau-20-1048","article-title":"A Higher Dose of Vancomycin Is Needed in Critically Ill Patients with Augmented Renal Clearance","volume":"9","author":"He","year":"2020","journal-title":"Transl Androl. Urol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1007\/s00228-019-02694-1","article-title":"Vancomycin Population Pharmacokinetics for Adult Patients with Sepsis or Septic Shock: Are Current Dosing Regimens Sufficient?","volume":"75","author":"Heffernan","year":"2019","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1111\/aas.13658","article-title":"Factors Increasing the Risk of Inappropriate Vancomycin Therapy in ICU Patients: A Prospective Observational Study","volume":"64","author":"Helset","year":"2020","journal-title":"Acta Anaesthesiol Scand."},{"key":"B35","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1097\/FTD.0000000000000346","article-title":"Augmented Renal Clearance in Patients with Febrile Neutropenia Is Associated with Increased Risk for Subtherapeutic Concentrations of Vancomycin","volume":"38","author":"Hirai","year":"2016","journal-title":"Ther. Drug Monit."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1002\/phar.1653","article-title":"Implications of Augmented Renal Clearance on Drug Dosing in Critically Ill Patients: A Focus on Antibiotics","volume":"35","author":"Hobbs","year":"2015","journal-title":"Pharmacotherapy"},{"key":"B37","doi-asserted-by":"publisher","first-page":"2941","DOI":"10.1093\/jac\/dkab278","article-title":"Impact of a Vancomycin Loading Dose on the Achievement of Target Vancomycin Exposure in the First 24 H and on the Accompanying Risk of Nephrotoxicity in Critically Ill Patients","volume":"76","author":"Hodiamont","year":"2021","journal-title":"J. Antimicrob. Chemother."},{"key":"B38","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.ijantimicag.2014.12.017","article-title":"Augmented Renal Clearance, Low \u03b2-lactam Concentrations and Clinical Outcomes in the Critically Ill: an Observational Prospective Cohort Study","volume":"45","author":"Huttner","year":"2015","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B39","doi-asserted-by":"publisher","first-page":"2502","DOI":"10.1111\/bcp.14657","article-title":"Population Pharmacokinetics of Vancomycin in Patients with External Ventricular drain-associated Ventriculitis","volume":"87","author":"Jalusic","year":"2021","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"115442","DOI":"10.1016\/j.diagmicrobio.2021.115442","article-title":"Optimizing Outcomes Using Vancomycin Therapeutic Drug Monitoring in Patients with MRSA Bacteremia: Trough Concentrations or Area under the Curve?","volume":"101","author":"Johnston","year":"2021","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"B41","doi-asserted-by":"publisher","first-page":"e01602","DOI":"10.1128\/AAC.01602-17","article-title":"Pharmacokinetic\/Pharmacodynamic Determinants of Vancomycin Efficacy in Enterococcal Bacteremia","volume":"62","author":"Jumah","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"B42","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s40560-016-0187-7","article-title":"Augmented Renal Clearance in Japanese Intensive Care Unit Patients: a Prospective Study","volume":"4","author":"Kawano","year":"2016","journal-title":"J. Intensive Care"},{"key":"B43","doi-asserted-by":"publisher","first-page":"E8","DOI":"10.3171\/2019.8.FOCUS19517","article-title":"Autonomic Dysfunction Following Traumatic Brain Injury: Translational Insights","volume":"47","author":"Khalid","year":"2019","journal-title":"Neurosurg. Focus"},{"key":"B44","first-page":"1","article-title":"KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease","volume":"3","author":"Kidney Disease: Improving Global Outcomes (Kdigo) Ckd Work Group","year":"2013","journal-title":"Kidney Int. Suppl."},{"key":"B45","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.ijantimicag.2016.06.022","article-title":"Comparison of the Pharmacokinetics of Vancomycin in Neurosurgical and Non-neurosurgical Patients","volume":"48","author":"Kim","year":"2016","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B46","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1111\/jcpt.12995","article-title":"A New Population Pharmacokinetic Model for Vancomycin in Patients with Variable Renal Function: Therapeutic Drug Monitoring Based on Extended Covariate Model Using CKD-EPI Estimation","volume":"44","author":"Kim","year":"2019","journal-title":"J. Clin. Pharm. Ther."},{"key":"B47","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12976-017-0054-9","article-title":"Establishment of a New Initial Dose Plan for Vancomycin Using the Generalized Linear Mixed Model","volume":"14","author":"Kourogi","year":"2017","journal-title":"Theor. Biol. Med. Model."},{"key":"B48","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s40262-017-0588-3","article-title":"Antibiotic Distribution into Cerebrospinal Fluid: Can Dosing Safely Account for Drug and Disease Factors in the Treatment of Ventriculostomy-Associated Infections?","volume":"57","author":"Kumta","year":"2018","journal-title":"Clin. Pharmacokinet."},{"key":"B49","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1002\/cpt.2203","article-title":"Key Challenges in Providing Effective Antibiotic Therapy for Critically Ill Patients with Bacterial Sepsis and Septic Shock","volume":"109","author":"Landersdorfer","year":"2021","journal-title":"Clin. Pharmacol. Ther."},{"key":"B50","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/1471-2369-13-124","article-title":"High Creatinine Clearance in Critically Ill Patients with Community-Acquired Acute Infectious Meningitis","volume":"13","author":"Lautrette","year":"2012","journal-title":"BMC Nephrol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1007\/s00228-017-2313-4","article-title":"Plasma and Cerebrospinal Fluid Population Pharmacokinetics of Vancomycin in Postoperative Neurosurgical Patients after Combined Intravenous and Intraventricular Administration","volume":"73","author":"Li","year":"2017","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"3960","DOI":"10.1002\/jps.24604","article-title":"Population Pharmacokinetics of Vancomycin in Postoperative Neurosurgical Patients","volume":"104","author":"Li","year":"2015","journal-title":"J. Pharm. Sci."},{"key":"B53","doi-asserted-by":"publisher","first-page":"3425","DOI":"10.1016\/j.xphs.2016.08.012","article-title":"Population Pharmacokinetics of Vancomycin in Postoperative Neurosurgical Patients and the Application in Dosing Recommendation","volume":"105","author":"Li","year":"2016","journal-title":"J. Pharm. Sci."},{"key":"B54","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s00228-015-1952-6","article-title":"Population Pharmacokinetics of Vancomycin in Adult Chinese Patients with post-craniotomy Meningitis and its Application in Individualised Dosage Regimens","volume":"72","author":"Lin","year":"2016","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3171\/2012.10.JNS12883","article-title":"Antibacterial Therapeutic Drug Monitoring in Cerebrospinal Fluid: Difficulty in Achieving Adequate Drug Concentrations","volume":"118","author":"Lonsdale","year":"2013","journal-title":"J. Neurosurg."},{"key":"B56","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3390\/pharmaceutics9030036","article-title":"Augmented Renal Clearance in Critical Illness: An Important Consideration in Drug Dosing","volume":"9","author":"Mahmoud","year":"2017","journal-title":"Pharmaceutics"},{"key":"B57","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1007\/s12028-015-0127-8","article-title":"Augmented Renal Clearance in Patients with Subarachnoid Hemorrhage","volume":"23","author":"May","year":"2015","journal-title":"Neurocrit. Care"},{"key":"B58","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1093\/jac\/dkv372","article-title":"Pharmacokinetics of Vancomycin and Dosing Recommendations for Trauma Patients","volume":"71","author":"Medell\u00edn-Garibay","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"B59","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1002\/phar.2234","article-title":"Conversion from Vancomycin Trough Concentration-Guided Dosing to Area under the Curve-Guided Dosing Using Two Sample Measurements in Adults: Implementation at an Academic Medical Center","volume":"39","author":"Meng","year":"2019","journal-title":"Pharmacotherapy"},{"key":"B60","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1097\/CCM.0000000000003716","article-title":"Enhanced Renal Clearance in Patients with Hemorrhagic Stroke","volume":"47","author":"Morbitzer","year":"2019","journal-title":"Crit. Care Med."},{"key":"B61","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.jss.2019.06.087","article-title":"Risk Factors and Clinical Outcomes Associated with Augmented Renal Clearance in Trauma Patients","volume":"244","author":"Mulder","year":"2019","journal-title":"J. Surg. Res."},{"key":"B62","doi-asserted-by":"publisher","first-page":"e00747","DOI":"10.1002\/prp2.747","article-title":"Augmented Renal Clearance in Critically Ill Patients with Cancer (ARCCAN Study): A Prospective Observational Study Evaluating Prevalence and Risk Factors","volume":"9","author":"Nazer","year":"2021","journal-title":"Pharmacol. Res. Perspect."},{"key":"B63","doi-asserted-by":"publisher","first-page":"e02042","DOI":"10.1128\/AAC.02042-17","article-title":"Prospective Trial on the Use of Trough Concentration versus Area under the Curve to Determine Therapeutic Vancomycin Dosing","volume":"62","author":"Neely","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"B64","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1128\/AAC.01653-13","article-title":"Are Vancomycin Trough Concentrations Adequate for Optimal Dosing?","volume":"58","author":"Neely","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"B65","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1159\/000507255","article-title":"Predictors of Augmented Renal Clearance in a Heterogeneous ICU Population as Defined by Creatinine and Cystatin C","volume":"144","author":"Nei","year":"2020","journal-title":"Nephron"},{"key":"B66","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.addr.2014.05.016","article-title":"Innovative Approaches to Optimizing the Delivery of Vancomycin in Individual Patients","volume":"77","author":"Pai","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B67","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.diagmicrobio.2013.10.011","article-title":"Aminoglycoside Dosing in Patients by Kidney Function and Area under the Curve: the Sawchuk-Zaske Dosing Method Revisited in the Era of Obesity","volume":"78","author":"Pai","year":"2014","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"B68","doi-asserted-by":"publisher","first-page":"3162","DOI":"10.1128\/AAC.02355-14","article-title":"Simplified Equations Using Two Concentrations to Calculate Area under the Curve for Antimicrobials with Concentration-dependent Pharmacodynamics: Daptomycin as a Motivating Example","volume":"58","author":"Pai","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"B69","doi-asserted-by":"publisher","first-page":"823","DOI":"10.23736\/S0375-9393.20.14991-5","article-title":"Acute Kidney Injury after Brain Injury: Does it Exist?","volume":"87","author":"Pesonen","year":"2021","journal-title":"Minerva Anestesiol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"573","DOI":"10.3947\/ic.2020.52.4.573","article-title":"Vancomycin Area under the Curve and Pharmacokinetic Parameters during the First 24 hours of Treatment in Critically Ill Patients Using Bayesian Forecasting","volume":"52","author":"Pongchaidecha","year":"2020","journal-title":"Infect. Chemother."},{"key":"B71","doi-asserted-by":"publisher","first-page":"2704","DOI":"10.1128\/AAC.01708-10","article-title":"Vancomycin Dosing in Critically Ill Patients: Robust Methods for Improved Continuous-Infusion Regimens","volume":"55","author":"Roberts","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"B72","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13613-015-0090-8","article-title":"Screening of Patients with Augmented Renal Clearance in ICU: Taking into Account the CKD-EPI Equation, the Age, and the Cause of Admission","volume":"5","author":"Ruiz","year":"2015","journal-title":"Ann. Intensive Care"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1093\/cid\/ciaa303","article-title":"Therapeutic Monitoring of Vancomycin for Serious Methicillin-Resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists","volume":"71","author":"Rybak","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"B74","doi-asserted-by":"publisher","first-page":"286","DOI":"10.3389\/fphys.2016.00286","article-title":"Intra-Parenchymal Renal Resistive Index Variation (IRRIV) Describes Renal Functional Reserve (RFR): Pilot Study in Healthy Volunteers","volume":"7","author":"Samoni","year":"2016","journal-title":"Front. Physiol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/BF01086153","article-title":"Pharmacokinetics of Dosing Regimens Which Utilize Multiple Intravenous Infusions: Gentamicin in Burn Patients","volume":"4","author":"Sawchuk","year":"1976","journal-title":"J. Pharmacokinet. Biopharm."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1007\/s00134-013-2909-9","article-title":"Systemic Inflammatory Response Syndrome Criteria and Vancomycin Dose Requirement in Patients with Sepsis","volume":"39","author":"Shimamoto","year":"2013","journal-title":"Intensive Care Med."},{"key":"B77","doi-asserted-by":"publisher","first-page":"3293","DOI":"10.1093\/jac\/dkaa320","article-title":"Assessing the Accuracy of Two Bayesian Forecasting Programs in Estimating Vancomycin Drug Exposure","volume":"75","author":"Shingde","year":"2020","journal-title":"J. Antimicrob. Chemother."},{"key":"B78","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.ijantimicag.2015.09.010","article-title":"Impact of Area under the Concentration-Time Curve to Minimum Inhibitory Concentration Ratio on Vancomycin Treatment Outcomes in Methicillin-Resistant Staphylococcus aureus Bacteraemia","volume":"46","author":"Song","year":"2015","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B79","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s12871-015-0065-1","article-title":"Evaluation of a Protocol for Vancomycin Administration in Critically Patients with and without Kidney Dysfunction","volume":"15","author":"Spadaro","year":"2015","journal-title":"BMC Anesthesiol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1002\/cpt.2113","article-title":"Evaluation of a Pilot Vancomycin Precision Dosing Advisory Service on Target Exposure Attainment Using an Interrupted Time Series Analysis","volume":"109","author":"Stocker","year":"2021","journal-title":"Clin. Pharmacol. Ther."},{"key":"B81","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.3390\/antibiotics10111421","article-title":"Cerebrospinal Fluid Concentrations of Meropenem and Vancomycin in Ventriculitis Patients Obtained by TDM-Guided Continuous Infusion","volume":"10","author":"Tiede","year":"2021","journal-title":"Antibiotics (Basel)"},{"key":"B82","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1177\/0310057X1804600107","article-title":"Prevalence of Augmented Renal Clearance and Performance of Glomerular Filtration Estimates in Indigenous Australian Patients Requiring Intensive Care Admission","volume":"46","author":"Tsai","year":"2018","journal-title":"Anaesth. Intensive Care"},{"key":"B83","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1002\/phar.2191","article-title":"Review and Validation of Bayesian Dose-Optimizing Software and Equations for Calculation of the Vancomycin Area under the Curve in Critically Ill Patients","volume":"38","author":"Turner","year":"2018","journal-title":"Pharmacotherapy"},{"key":"B84","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1213\/ANE.0b013e3181f7107d","article-title":"Augmented Creatinine Clearance in Traumatic Brain Injury","volume":"111","author":"Udy","year":"2010","journal-title":"Anesth. Analg"},{"key":"B85","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1097\/CCM.0000000000000029","article-title":"Augmented Renal Clearance in the ICU: Results of a Multicenter Observational Study of Renal Function in Critically Ill Patients with normal Plasma Creatinine Concentrations*","volume":"42","author":"Udy","year":"2014","journal-title":"Crit. Care Med."},{"key":"B86","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.ijantimicag.2016.12.022","article-title":"Association between Augmented Renal Clearance and Clinical Outcomes in Patients Receiving \u03b2-lactam Antibiotic Therapy by Continuous or Intermittent Infusion: a Nested Cohort Study of the BLING-II Randomised, Placebo-Controlled, Clinical Trial","volume":"49","author":"Udy","year":"2017","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B87","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1089\/neu.2015.4328","article-title":"Augmented Renal Clearance in Traumatic Brain Injury: A Single-Center Observational Study of Atrial Natriuretic Peptide, Cardiac Output, and Creatinine Clearance","volume":"34","author":"Udy","year":"2017","journal-title":"J. Neurotrauma"},{"key":"B88","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.ijantimicag.2010.02.013","article-title":"Augmented Renal Clearance in the Intensive Care Unit: an Illustrative Case Series","volume":"35","author":"Udy","year":"2010","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B89","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2165\/11318140-000000000-00000","article-title":"Augmented Renal Clearance: Implications for Antibacterial Dosing in the Critically Ill","volume":"49","author":"Udy","year":"2010","journal-title":"Clin. Pharmacokinet."},{"key":"B90","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.addr.2017.09.019","article-title":"The Effects of Major Burn Related Pathophysiological Changes on the Pharmacokinetics and Pharmacodynamics of Drug Use: An Appraisal Utilizing Antibiotics","volume":"123","author":"Udy","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B91","doi-asserted-by":"publisher","first-page":"R35","DOI":"10.1186\/cc12544","article-title":"Augmented Renal Clearance in Septic and Traumatized Patients with normal Plasma Creatinine Concentrations: Identifying At-Risk Patients","volume":"17","author":"Udy","year":"2013","journal-title":"Crit. Care"},{"key":"B92","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1378\/chest.11-1671","article-title":"Subtherapeutic Initial \u03b2-lactam Concentrations in Select Critically Ill Patients: Association between Augmented Renal Clearance and Low Trough Drug Concentrations","volume":"142","author":"Udy","year":"2012","journal-title":"Chest"},{"key":"B93","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1111\/bcp.14411","article-title":"Personalised Dosing of Vancomycin: A Prospective and Retrospective Comparative Quasi-Experimental Study","volume":"87","author":"Vali","year":"2021","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1097\/TA.0000000000002492","article-title":"Vancomycin Dosing in Critically Ill Trauma Patients: The VANCTIC Study","volume":"87","author":"Villanueva","year":"2019","journal-title":"J. Trauma Acute Care Surg."},{"key":"B95","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.ijantimicag.2019.09.018","article-title":"Determination of Optimal Loading and Maintenance Doses for Continuous Infusion of Vancomycin in Critically Ill Patients: Population Pharmacokinetic Modelling and Simulations for Improved Dosing Schemes","volume":"54","author":"Vu","year":"2019","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B96","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1515\/med-2018-0068","article-title":"Pharmacokinetics of Vancomycin in Patients with Different Renal Function Levels","volume":"13","author":"Zaric","year":"2018","journal-title":"Open Med. (Wars)"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.835557\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T19:21:00Z","timestamp":1647890460000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.835557\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,21]]},"references-count":96,"alternative-id":["10.3389\/fphar.2022.835557"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.835557","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,21]]},"article-number":"835557"}}